News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Diko Kazandjian: IsaVRD more is better
Photo from Diko Kazandjian/X
Jun 5, 2024, 14:51

Diko Kazandjian: IsaVRD more is better

Dickran (Diko) Kazandjian, Professor of Medicine at the Sylvester Comprehensive Cancer Center and Board Member of OncoDaily, shared on X/Twitter:

”IsaVRD (Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone (VRD)). More is better. For transplant-eligible patients with newly diagnosed multiple myeloma who are under 80 years old.”

Source: Diko Kazandjian/X

Bortezomib cancer dexamethasone Diko Kazandjian Isatuximab IsaVRD Lenalidomide multiple myeloma OncoDaily Oncology Sylvester Comprehensive Cancer Center
Special Coverage
Blog
Jan 15, 2025, 16:31
An excerpt from the just-concluded Conversations on Cancer panel discussion - FDA Oncology
Insight
Jan 15, 2025, 16:26
An IGG gene signature links to longevity in breast cancer survivors - ESMO Open
Blog
Jan 15, 2025, 16:21
Zainab Shinkafi-Bagudu: Excited to introduce "Learning Tuesday with Dr. ZSB"
Insight
Jan 15, 2025, 16:20
Liquid Biopsy Breakthrough - International Society of Liquid Biopsy
Blog
Jan 15, 2025, 16:16
Monica Bertagnolli is ending her tenure as NIH director
Blog
Jan 15, 2025, 16:15
Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment
Insight
Jan 15, 2025, 16:13
Nihar Desai: A case of elevated white cell count in a 60-year-old male
Blog
Jan 15, 2025, 16:11
Megan-Claire Chase: Attending the Stand Up for Trans Georgians Rally
Positive
Jan 15, 2025, 15:57
William Pao: Breakthrough - The Quest for Life-Changing Medicines
Science
Jan 15, 2025, 15:32
Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer
Insight
Jan 15, 2025, 15:27
Sylvester Study Highlights Global Trends in Lung Cancer Risk Factors: Tobacco, Pollution, and Asbestos
Insight
Jan 15, 2025, 15:20
Karen Knudsen: Clinical trials are the most advanced form of cancer care